Although our study endpoints did not reach statistical significance, as there was insufficient evidence that individuals proactively changed their lifestyle, our findings can guide future trials using extended biomarker assessments to evaluate the value of presymptomatic AMD genetic testing in larger and more diverse populations.
← all excerpts
Carotenoid Status and Psychological Impact of Presymptomatic Macular Degeneration Genetic Risk Assessment: The MAGENTA Randomized Trial.
1
—
—